Schedule 13D ownership disclosure

Armata Pharmaceuticals, Inc.

Security class unavailable · CUSIP: 04216R102

Event date: 2020-02-12

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
16.6600%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000899140-20-000160
Form type
SC 13D
Filer
Armata Pharmaceuticals, Inc.
CIK
CIK 921114
Filed
Feb 14, 2020
Reporting period
Feb 12, 2020
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub